{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:49Z","timestamp":1787022229859,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["94480"],"award-info":[{"award-number":["94480"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1378\/chest.11-1597","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T19:01:32Z","timestamp":1344366092000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Bronchodilator Use and the Risk of Arrhythmia in COPD"],"prefix":"10.1016","volume":"142","author":[{"given":"Machelle","family":"Wilchesky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1378\/chest.11-1597_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/ajrccm\/138.4.850","article-title":"High-dose inhaled albuterol in severe chronic airflow limitation","volume":"138","author":"Vathenen","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1378\/chest.11-1597_bib2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1164\/ajrccm\/139.5.1188","article-title":"Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study","volume":"139","author":"Gross","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"6662","key":"10.1378\/chest.11-1597_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.297.6662.1506","article-title":"Dose response relation to oral theophylline in severe chronic obstructive airways disease","volume":"297","author":"Chrystyn","year":"1988","journal-title":"BMJ"},{"issue":"4","key":"10.1378\/chest.11-1597_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1183\/09031936.93.04040415","article-title":"Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis","volume":"4","author":"Higgins","year":"1991","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.11-1597_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1378\/chest.10-2499","article-title":"Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan Cohort Study","volume":"142","author":"Wilchesky","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-1597_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0895-4356(03)00246-4","article-title":"Validation of diagnostic codes within medical services claims","volume":"57","author":"Wilchesky","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1378\/chest.11-1597_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Qu\u00e9bec","volume":"48","author":"Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1378\/chest.11-1597_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/oxfordjournals.aje.a117651","article-title":"Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992","volume":"142","author":"Levy","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1378\/chest.11-1597_bib9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1183\/09031936.06.00043005","article-title":"Low-dose inhaled and nasal corticosteroid use and the risk of cataracts","volume":"27","author":"Ernst","year":"2006","journal-title":"Eur Respir J"},{"issue":"15","key":"10.1378\/chest.11-1597_bib10","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study","volume":"160","author":"Blais","year":"2000","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1378\/chest.11-1597_bib11","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of use of lipid-lowering medications: a cross-national study","volume":"279","author":"Avorn","year":"1998","journal-title":"JAMA"},{"issue":"9","key":"10.1378\/chest.11-1597_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.11-1597_bib13","series-title":"Pharmacoepidemiology","first-page":"785","article-title":"Novel approaches to pharmacoepidemiology study design and statistical analysis","author":"Suissa","year":"2000"},{"issue":"3","key":"10.1378\/chest.11-1597_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","article-title":"Immeasurable time bias in observational studies of drug effects on mortality","volume":"168","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1378\/chest.11-1597_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2307\/2530744","article-title":"Biased selection of controls for case-control analyses of cohort studies","volume":"40","author":"Lubin","year":"1984","journal-title":"Biometrics"},{"issue":"6","key":"10.1378\/chest.11-1597_bib16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","article-title":"Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study","volume":"21","author":"Buch","year":"2003","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1378\/chest.11-1597_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/milmed\/146.12.856","article-title":"Cardiac arrhythmias associated with acute respiratory failure in chronic obstructive pulmonary disease","volume":"146","author":"Khokhar","year":"1981","journal-title":"Mil Med"},{"issue":"1","key":"10.1378\/chest.11-1597_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-8703(75)90006-X","article-title":"Type of cardiac dysrhythmias in respiratory failure","volume":"89","author":"Sideris","year":"1975","journal-title":"Am Heart J"},{"issue":"5","key":"10.1378\/chest.11-1597_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1183\/09031936.04.00049604","article-title":"Inhaled corticosteroids and the risk of a first exacerbation in COPD patients","volume":"23","author":"de Melo","year":"2004","journal-title":"Eur Respir J"},{"issue":"433","key":"10.1378\/chest.11-1597_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/01621459.1996.10476660","article-title":"Statistics in epidemiology: the case-control study","volume":"91","author":"Breslow","year":"1996","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1378\/chest.11-1597_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.200708-1290OC","article-title":"Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort","volume":"177","author":"Langsetmo","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.11-1597_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","article-title":"The problem of \u201cprotopathic bias\u201d in case-control studies","volume":"68","author":"Horwitz","year":"1980","journal-title":"Am J Med"},{"issue":"5","key":"10.1378\/chest.11-1597_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pcad.2006.10.003","article-title":"Why does chronic heart failure cause breathlessness and fatigue?","volume":"49","author":"Witte","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1378\/chest.11-1597_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1054\/jcaf.2001.26905","article-title":"Chronic heart failure in the community: missed diagnosis and missed opportunities","volume":"7","author":"Akosah","year":"2001","journal-title":"J Card Fail"},{"issue":"3 pt 1","key":"10.1378\/chest.11-1597_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1164\/ajrccm.161.3.9904006","article-title":"The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists","volume":"161","author":"Au","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.11-1597_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/archinternmed.2011.171","article-title":"Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on \u201cInhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease.\u201d","volume":"171","author":"Singh","year":"2011","journal-title":"Arch Intern Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212604425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212604425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:30:08Z","timestamp":1757917808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212604425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0012369212604425"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-1597","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchodilator Use and the Risk of Arrhythmia in COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-1597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}